A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis

​ Conditions: Ulcerative Colitis (UC)

Interventions: Drug: PTT-621 Tablets

Sponsors: Pyrotech Therapeutics, Inc.

Not yet recruiting Conditions: Ulcerative Colitis (UC)
Interventions: Drug: PTT-621 Tablets
Sponsors: Pyrotech Therapeutics, Inc.
Not yet recruiting